Cargando…

In silico Drug Repurposing of Anticancer Drug 5-FU and Analogues Against SARS-CoV-2 Main Protease: Molecular Docking, Molecular Dynamics Simulation, Pharmacokinetics and Chemical Reactivity Studies

BACKGROUND: Since the last COVID-19 outbreak, several approaches have been given a try to quickly tackle this global calamity. One of the well-established strategies is the drug repurposing, which consists in finding new therapeutic uses for approved drugs. Following the same paradigm, we report in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matondo, Aristote, Dendera, Washington, Isamura, Bienfait Kabuyaya, Ngbolua, Koto-te-Nyiwa, Mambo, Hilaire V S, Muzomwe, Mayaliwa, Mudogo, Virima
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9391940/ https://www.ncbi.nlm.nih.gov/pubmed/35996620 http://dx.doi.org/10.2147/AABC.S366111

Ejemplares similares

An Integrated Analysis of Mechanistic Insights into Biomolecular Interactions and Molecular Dynamics of Bio-Inspired Cu(II) and Zn(II) Complexes towards DNA/BSA/SARS-CoV-2 3CL(pro) by Molecular Docking-Based Virtual Screening and FRET Detection
por: Sakthikumar, Karunganathan, et al.
Publicado: (2022)

New Insights into the (A)Synchronicity of Diels–Alder Reactions: A Theoretical Study Based on the Reaction Force Analysis and Atomic Resolution of Energy Derivatives
por: Isamura, Bienfait Kabuyaya, et al.
Publicado: (2022)

Identification of potential inhibitors of SARS-CoV-2 main protease from Aloe vera compounds: A molecular docking study
por: Mpiana, Pius T., et al.
Publicado: (2020)

Comprehensive Assessment of Biomolecular Interactions of Morpholine-Based Mixed Ligand Cu(II) and Zn(II) Complexes of 2,2′-Bipyridine as Potential Anticancer and SARS-CoV-2 Agents: A Synergistic Experimental and Structure-Based Virtual Screening
por: Sakthikumar, Karunganathan, et al.
Publicado: (2022)

Exploring the antioxidant, antimicrobial, cytotoxic and biothermodynamic properties of novel morpholine derivative bioactive Mn(ii), Co(ii) and Ni(ii) complexes – combined experimental and theoretical measurements towards DNA/BSA/SARS-CoV-2 3CL(Pro)
por: Sakthikumar, Karunganathan, et al.
Publicado: (2023)

AMADAR: a python-based package for large scale prediction of Diels–Alder transition state geometries and IRC path analysis
por: Isamura, Bienfait K., et al.
Publicado: (2022)

Ethnopharmacological Survey and Antisickling Activity of Plants Used in the Management of Sickle Cell Disease in Kikwit City, DR Congo
por: Kitadi, Jules Munganga, et al.
Publicado: (2020)

COVID-19 Molecular Pathophysiology: Acetylation of Repurposing Drugs
por: Lee, Jong Hoon, et al.
Publicado: (2022)

Anti-sickling Activity of Ursolic Acid Isolated from the Leaves of Ocimum gratissimum L. (Lamiaceae)
por: Tshilanda, Dorothée Dinangayi, et al.
Publicado: (2015)

COVID-19: molecular targets, drug repurposing and new avenues for drug discovery
por: Senger, Mario Roberto, et al.
Publicado: (2020)

Molecularly Guided Drug Repurposing for Cholangiocarcinoma: An Integrative Bioinformatic Approach
por: Venkatraman, Simran, et al.
Publicado: (2022)

5-FU Metabolism in Cancer and Orally-Administrable 5-FU Drugs
por: Miura, Koh, et al.
Publicado: (2010)

Antiplasmodial Ealapasamines A-C,‘Mixed’ Naphthylisoquinoline Dimers from the Central African Liana Ancistrocladus ealaensis
por: Tshitenge, Dieudonné Tshitenge, et al.
Publicado: (2017)

Michellamines A(6) and A(7), and further mono- and dimeric naphthylisoquinoline alkaloids from a Congolese Ancistrocladus liana and their antiausterity activities against pancreatic cancer cells
por: Lombe, Blaise Kimbadi, et al.
Publicado: (2018)

Antiprotozoal dimeric naphthylisoquinolines, mbandakamines B(3) and B(4), and related 5,8′-coupled monomeric alkaloids, ikelacongolines A–D, from a Congolese Ancistrocladus liana
por: Mufusama, Jean-Pierre, et al.
Publicado: (2019)

Molecular docking and molecular dynamic simulation approaches for drug development and repurposing of drugs for severe acute respiratory syndrome-Coronavirus-2
por: Subhaswaraj, Pattnaik, et al.
Publicado: (2022)

An Unusually Broad Series of Seven Cyclombandakamines, Bridged Dimeric Naphthylisoquinoline Alkaloids from the Congolese Liana Ancistrocladus ealaensis
por: Tshitenge, Dieudonné Tshitenge, et al.
Publicado: (2019)

Drug repurposing for SARS-CoV-2 main protease: Molecular docking and molecular dynamics investigations
por: Omer, Samia E., et al.
Publicado: (2022)

Homopharma: A new concept for exploring the molecular binding mechanisms and drug repurposing
por: Chiu, Yi-Yuan, et al.
Publicado: (2014)

Repurposing of known drugs for COVID-19 using molecular docking and simulation analysis
por: Bhanu1, Piyush, et al.
Publicado: (2023)

Editorial: Drug Repurposing
por: Pantziarka, Pan, et al.
Publicado: (2019)

Antifungal Drug Repurposing
por: Kim, Jong H., et al.
Publicado: (2020)

Drug repurposing in cardiology
por: van Driel, B. O., et al.
Publicado: (2020)

COVID-19: Vaccine Delivery System, Drug Repurposing and Application of Molecular Modeling Approach
por: Abd El Hadi, Soha R, et al.
Publicado: (2021)

Tackling the Behavior of Cancer Cells: Molecular Bases for Repurposing Antipsychotic Drugs in the Treatment of Glioblastoma
por: Persico, Michele, et al.
Publicado: (2022)

Phenotypic screening of low molecular weight compounds is rich ground for repurposed, on-target drugs
por: Lipinski, Christopher A., et al.
Publicado: (2022)

Repurposing of antiviral drugs for COVID-19 and impact of repurposed drugs on the nervous system
por: Punekar, Madhura, et al.
Publicado: (2022)

Network analysis and molecular mapping for SARS-CoV-2 to reveal drug targets and repurposing of clinically developed drugs
por: More, Shweta A., et al.
Publicado: (2021)

Hidradenitis Suppurativa and Comorbid Disorder Biomarkers, Druggable Genes, New Drugs and Drug Repurposing—A Molecular Meta-Analysis
por: Zouboulis, Viktor A., et al.
Publicado: (2021)

Main protease inhibitors and drug surface hotspots for the treatment of COVID-19: A drug repurposing and molecular docking approach
por: Hasan, Mahmudul, et al.
Publicado: (2021)

Repurposing of approved drugs for targeting CDK4/6 and aromatase protein using molecular docking and molecular dynamics studies
por: yousif, Fatima A., et al.
Publicado: (2023)

Drug Repurposing for Schistosomiasis: Combinations of Drugs or Biomolecules
por: Gouveia, Maria João, et al.
Publicado: (2018)

Molecular targets and system biology approaches for drug repurposing against SARS-CoV-2
por: Singh, Rahul Kunwar, et al.
Publicado: (2020)

Mycophenolate suppresses inflammation by inhibiting prostaglandin synthases: a study of molecular and experimental drug repurposing
por: Al-Hizab, Fahad, et al.
Publicado: (2021)

Molecular-evaluated and explainable drug repurposing for COVID-19 using ensemble knowledge graph embedding
por: Islam, Md Kamrul, et al.
Publicado: (2023)

Memantine hydrochloride: a drug to be repurposed against Chikungunya virus?
por: Pereira, Anna Karla dos Santos, et al.
Publicado: (2021)

Drug repurposing for identification of potential spike inhibitors for SARS-CoV-2 using molecular docking and molecular dynamics simulations
por: Lazniewski, Michal, et al.
Publicado: (2022)

Drug Repurposing against KRAS Mutant G12C: A Machine Learning, Molecular Docking, and Molecular Dynamics Study
por: Srisongkram, Tarapong, et al.
Publicado: (2022)

Repurposing of approved cardiovascular drugs
por: Ishida, Junichi, et al.
Publicado: (2016)

Drug repurposing with network reinforcement
por: Nam, Yonghyun, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_j0bku06hkcu2km5m6q2pm57quu